| Literature DB >> 35112318 |
Xuezhen Ma1, Xuesong Wang2, Xuexiao Ma3, Xiugong Zhang4, Xiaojin Gong4, Ruifu Sun4, Sunny H Wong5,6, Matthew T V Chan7, William Ka Kei Wu6,7.
Abstract
Spinal cord injury (SCI) is a disabling condition for which therapeutic options are limited. Increasing number of microarray and next-generation sequencing studies have demonstrated that SCI coincides with altered expression of circular RNAs (circRNAs) in the damaged tissue. Emerging functional evidence further pinpointed specific differentially expressed circRNAs (e.g., circ-HIPK3, cicRNA.7079, circRNA_01477, circRNA-2960, and circ_0001723) for their effects on cellular processes relevant to SCI repair and regeneration, including neuronal apoptosis, astrocyte activation, and neuroinflammation, via sponging SCI-related microRNAs. Although circRNAs and their target microRNAs appear to be good candidates for therapeutic exploitation in SCI, further investigation into the efficient delivery of these regulatory molecules in a cell-type specific manner is a pre-requisite for translating these basic discoveries into clinical benefits.Entities:
Keywords: Spinal cord injury; ceRNA; circRNA; microRNA
Mesh:
Substances:
Year: 2022 PMID: 35112318 DOI: 10.1007/s12035-021-02721-2
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590